CYR61 confers chemoresistance by upregulating survivin expression in triple-negative breast cancer
Carcinogenesis · 2024
DOI: 10.1093/carcin/bgae013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2024. Verfasst von Hyungjoo Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, Hanyang University, Seoul 04763, Korea. Hauptthemen laut MEDLINE: Cysteine-Rich Protein 61, Triple Negative Breast Neoplasms, Survivin, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Cysteine-rich angiogenic inducer 61 (CYR61) is a protein from the CCN family of matricellular proteins that play diverse regulatory roles in the extracellular matrix. CYR61 is involved in cell adhesion, migration, proliferation, differentiation, apoptosis, and senescence. Here, we show that CYR61 induces chemoresistance in triple-negative breast cancer (TNBC). We observed that CYR61 is overexpressed in TNBC patients, and CYR61 expression correlates negatively with the survival of patients who receive chemotherapy. CYR61 knockdown reduced cell migration, sphere formation and the cancer stem cell (CSC) population and increased the chemosensitivity of TNBC cells. Mechanistically, CYR61 activated Wnt/β-catenin signaling and increased survivin expression, which are associated with chemoresistance, the epithelial–mesenchymal transition, and CSC-like phenotypes. Altogether, our study demonstrates a novel function of CYR61 in chemotherapy resistance in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Life Science, Hanyang University, Seoul 04763, Korea.
- Natural Science Institute, Hanyang University, Seoul 04763, Korea.
- Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul 04763, Korea.
ORCID-Profile: Incheol Shin
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kim, H., Son, S., Ko, Y., Lim, H., Lee, J., Lee, K. M., & Shin, I. (2024). CYR61 confers chemoresistance by upregulating survivin expression in triple-negative breast cancer. Carcinogenesis. https://doi.org/10.1093/carcin/bgae013
Vancouver
Kim H, Son S, Ko Y, Lim H, Lee J, Lee KM, et al. CYR61 confers chemoresistance by upregulating survivin expression in triple-negative breast cancer. Carcinogenesis. 2024. doi:10.1093/carcin/bgae013
BibTeX
@article{Kim2024,
author = {Kim, Hyungjoo and Son, Seogho and Ko, Yunhyo and Lim, Hogeun and Lee, Joohyung and Lee, Kyung-Min and Shin, Incheol},
title = {CYR61 confers chemoresistance by upregulating survivin expression in triple-negative breast cancer},
journal = {Carcinogenesis},
year = {2024},
doi = {10.1093/carcin/bgae013}
}
EUVIMED